• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PI3K/AKT信号通路的异常表达与肝细胞癌的凋亡抵抗有关。

Aberrant expression of PI3K/AKT signaling is involved in apoptosis resistance of hepatocellular carcinoma.

作者信息

Wang Zhuangqiang, Cui Xiaopeng, Hao Gaopeng, He Jiefeng

机构信息

Department of Hepatobiliary Surgery, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Third Hospital of Shanxi Medical University, No. 99 Longcheng Street, Taiyuan 030032, Shanxi, China.

Department of General Surgery, Shanxi Provincial People's Hospital, Taiyuan 030032, Shanxi, China.

出版信息

Open Life Sci. 2021 Sep 27;16(1):1037-1044. doi: 10.1515/biol-2021-0101. eCollection 2021.

DOI:10.1515/biol-2021-0101
PMID:34632072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8477673/
Abstract

Phosphatidylinositol 3-kinase (PI3K)/AKT signaling is a crucial pathway for cell survival and proliferation, which are regulated by several growth factors and activated receptors. Upregulated PI3K/AKT signaling molecules were reported in several cancers and they are associated with altered cellular functions, leading to oncogenesis. Here, we have examined the implications of elevated PI3K/AKT expression in the apoptosis resistance of human hepatocellular carcinoma (HCC) Huh7 cells. We showed that PI3K/AKT signaling is significantly upregulated in Huh7 cells by quantitative polymerase chain reaction and protein expression analysis. Also, perversely upregulated PI3K/AKT signaling Huh7 cells are highly resistant to treatment with chemotherapy drugs (docetaxel and sorafenib) and acquired apoptosis resistance through downregulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten). Hence, we have investigated the effect of PTEN overexpression on apoptosis induction in Huh7 cells. We showed that PTEN overexpressed Huh7 cells became more sensitive toward the aforesaid drugs and induced apoptotic cell death due to intracellular reactive oxygen species (ROS) generation. Concurrently, the overexpression of PTEN leads to the activation of mitochondria facilitated intrinsic apoptosis, evidenced by upregulated cytochrome C, caspase 3, and caspase 9. Collectively, our data suggest that the aberrant expression of PI3K/AKT signaling contributes to apoptosis resistance in HCC.

摘要

磷脂酰肌醇3激酶(PI3K)/AKT信号通路是细胞存活和增殖的关键途径,受多种生长因子和激活受体的调控。在几种癌症中均报道了PI3K/AKT信号分子上调,它们与细胞功能改变有关,从而导致肿瘤发生。在此,我们研究了PI3K/AKT表达升高对人肝癌(HCC)Huh7细胞凋亡抗性的影响。通过定量聚合酶链反应和蛋白质表达分析,我们发现Huh7细胞中PI3K/AKT信号通路显著上调。此外,PI3K/AKT信号通路异常上调的Huh7细胞对化疗药物(多西他赛和索拉非尼)治疗具有高度抗性,并通过下调肿瘤抑制蛋白PTEN(第10号染色体上缺失的磷酸酶和张力蛋白同源物)获得凋亡抗性。因此,我们研究了PTEN过表达对Huh7细胞凋亡诱导的影响。我们发现PTEN过表达的Huh7细胞对上述药物变得更加敏感,并由于细胞内活性氧(ROS)的产生而诱导凋亡性细胞死亡。同时,PTEN的过表达导致线粒体促进的内源性凋亡激活,细胞色素C、半胱天冬酶3和半胱天冬酶9的上调证明了这一点。总体而言,我们的数据表明PI3K/AKT信号通路的异常表达导致HCC细胞凋亡抗性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/287d/8477673/a8957143240b/j_biol-2021-0101-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/287d/8477673/6da854fc4a9a/j_biol-2021-0101-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/287d/8477673/0f8524949ad5/j_biol-2021-0101-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/287d/8477673/4cb7bda26e75/j_biol-2021-0101-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/287d/8477673/a8957143240b/j_biol-2021-0101-fig004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/287d/8477673/6da854fc4a9a/j_biol-2021-0101-fig001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/287d/8477673/0f8524949ad5/j_biol-2021-0101-fig002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/287d/8477673/4cb7bda26e75/j_biol-2021-0101-fig003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/287d/8477673/a8957143240b/j_biol-2021-0101-fig004.jpg

相似文献

1
Aberrant expression of PI3K/AKT signaling is involved in apoptosis resistance of hepatocellular carcinoma.PI3K/AKT信号通路的异常表达与肝细胞癌的凋亡抵抗有关。
Open Life Sci. 2021 Sep 27;16(1):1037-1044. doi: 10.1515/biol-2021-0101. eCollection 2021.
2
Activation of phosphatidylinositol 3-kinase/Akt signaling pathway mediates acquired resistance to sorafenib in hepatocellular carcinoma cells.磷脂酰肌醇 3-激酶/蛋白激酶 B 信号通路的激活介导肝癌细胞对索拉非尼获得性耐药。
J Pharmacol Exp Ther. 2011 Apr;337(1):155-61. doi: 10.1124/jpet.110.175786. Epub 2011 Jan 4.
3
New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.深入了解 Notch1 对 PI3K-AKT-mTOR1 信号轴的调控:γ-分泌酶抑制剂耐药 T 细胞急性淋巴细胞白血病的靶向治疗。
Cell Signal. 2014 Jan;26(1):149-61. doi: 10.1016/j.cellsig.2013.09.021. Epub 2013 Oct 16.
4
Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.RAF/MEK/ERK和PI3K/PTEN/AKT信号通路在恶性转化和耐药中的作用。
Adv Enzyme Regul. 2006;46:249-79. doi: 10.1016/j.advenzreg.2006.01.004. Epub 2006 Jul 18.
5
Synergistic anticancer activity of 20(S)-Ginsenoside Rg3 and Sorafenib in hepatocellular carcinoma by modulating PTEN/Akt signaling pathway.20(S)-人参皂苷 Rg3 与索拉非尼通过调控 PTEN/Akt 信号通路协同抑制肝癌。
Biomed Pharmacother. 2018 Jan;97:1282-1288. doi: 10.1016/j.biopha.2017.11.006. Epub 2017 Dec 14.
6
SPAG6 silencing induces apoptosis in the myelodysplastic syndrome cell line SKM‑1 via the PTEN/PI3K/AKT signaling pathway in vitro and in vivo.SPAG6 沉默通过体外和体内的 PTEN/PI3K/AKT 信号通路诱导骨髓增生异常综合征细胞系 SKM-1 凋亡。
Int J Oncol. 2018 Jul;53(1):297-306. doi: 10.3892/ijo.2018.4390. Epub 2018 May 2.
7
Hydrazinocurcumin and 5-fluorouracil enhance apoptosis and restrain tumorigenicity of HepG2 cells via disrupting the PTEN-mediated PI3K/Akt signaling pathway.肼基姜黄素和 5-氟尿嘧啶通过破坏 PTEN 介导的 PI3K/Akt 信号通路增强 HepG2 细胞的凋亡并抑制其致瘤性。
Biomed Pharmacother. 2020 Sep;129:109851. doi: 10.1016/j.biopha.2020.109851. Epub 2020 Jun 17.
8
Elevated PDK1 Expression Drives PI3K/AKT/MTOR Signaling Promotes Radiation-Resistant and Dedifferentiated Phenotype of Hepatocellular Carcinoma.PDK1 表达升高驱动 PI3K/AKT/MTOR 信号促进肝癌的辐射抵抗和去分化表型。
Cells. 2020 Mar 18;9(3):746. doi: 10.3390/cells9030746.
9
MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.微小RNA-21通过PTEN/蛋白激酶B信号通路抑制自噬,从而介导肝癌细胞对索拉非尼的耐药性。
Oncotarget. 2015 Oct 6;6(30):28867-81. doi: 10.18632/oncotarget.4814.
10
BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy.BEZ235通过抑制PI3K/AKT/mTOR和诱导自噬增加肝细胞癌对索拉非尼的敏感性。
Biomed Res Int. 2021 Apr 16;2021:5556306. doi: 10.1155/2021/5556306. eCollection 2021.

引用本文的文献

1
The functional roles of competitive endogenous RNA (ceRNA) networks in apoptosis in human cancers: The circRNA/miRNA/mRNA regulatory axis and cell signaling pathways.竞争性内源性RNA(ceRNA)网络在人类癌症细胞凋亡中的功能作用:环状RNA/微小RNA/信使RNA调控轴与细胞信号通路
Heliyon. 2024 Aug 31;10(21):e37089. doi: 10.1016/j.heliyon.2024.e37089. eCollection 2024 Nov 15.
2
New insights into fibrotic signaling in hepatocellular carcinoma.肝细胞癌中纤维化信号传导的新见解。
Front Oncol. 2023 Nov 22;13:1196298. doi: 10.3389/fonc.2023.1196298. eCollection 2023.
3
Deciphering STAT3 signaling potential in hepatocellular carcinoma: tumorigenesis, treatment resistance, and pharmacological significance.

本文引用的文献

1
Evolution of systemic treatment for advanced hepatocellular carcinoma.晚期肝细胞癌全身治疗的进展
Kaohsiung J Med Sci. 2021 Aug;37(8):643-653. doi: 10.1002/kjm2.12401. Epub 2021 Jul 2.
2
Clinical Characteristics of Long-Term Survivors After Sorafenib Treatment for Unresectable Hepatocellular Carcinoma: A Korean National Multicenter Retrospective Cohort Study.索拉非尼治疗不可切除肝细胞癌后长期生存者的临床特征:一项韩国全国多中心回顾性队列研究
J Hepatocell Carcinoma. 2021 Jun 18;8:613-623. doi: 10.2147/JHC.S304439. eCollection 2021.
3
Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis.
解析 STAT3 信号通路在肝细胞癌中的作用:肿瘤发生、治疗耐药及药理学意义。
Cell Mol Biol Lett. 2023 Apr 21;28(1):33. doi: 10.1186/s11658-023-00438-9.
4
A cellular senescence-related genes model allows for prognosis and treatment stratification of hepatocellular carcinoma: A bioinformatics analysis and experimental verification.一种细胞衰老相关基因模型可用于肝细胞癌的预后评估和治疗分层:生物信息学分析与实验验证
Front Genet. 2023 Jan 12;13:1099148. doi: 10.3389/fgene.2022.1099148. eCollection 2022.
5
Overexpression of Induces the Proliferation of Hepatocarcinoma and Increases Metastatic Potential by Increasing Migratory Ability and Angiogenic Capacity.过表达 可诱导肝癌细胞增殖,并通过增加迁移能力和血管生成能力增加转移潜能。
Mol Cells. 2022 Dec 31;45(12):935-949. doi: 10.14348/molcells.2022.0105. Epub 2022 Dec 8.
6
Protein phosphatases regulate the liver microenvironment in the development of hepatocellular carcinoma.蛋白磷酸酶调控肝癌发生发展中的肝微环境。
Exp Mol Med. 2022 Nov;54(11):1799-1813. doi: 10.1038/s12276-022-00883-0. Epub 2022 Nov 15.
7
Primary-like Human Hepatocytes Genetically Engineered to Obtain Proliferation Competence as a Capable Application for Energy Metabolism Experiments in In Vitro Oncologic Liver Models.经过基因工程改造以获得增殖能力的原代样人肝细胞,作为体外肿瘤性肝模型中能量代谢实验的有效应用。
Biology (Basel). 2022 Aug 9;11(8):1195. doi: 10.3390/biology11081195.
基于复发后生存的手术切除后肝细胞癌早期与晚期复发的比较:一项国际多机构分析。
J Gastrointest Surg. 2021 Jan;25(1):125-133. doi: 10.1007/s11605-020-04553-2. Epub 2020 Mar 3.
4
Molecular Signaling Pathways and Therapeutic Targets in Hepatocellular Carcinoma.肝细胞癌中的分子信号通路与治疗靶点
Cancers (Basel). 2020 Feb 20;12(2):491. doi: 10.3390/cancers12020491.
5
The Role of the LY294002 - A Non-Selective Inhibitor of Phosphatidylinositol 3-Kinase (PI3K) Pathway- in Cell Survival and Proliferation in Cell Line SCC-25.LY294002(一种磷脂酰肌醇3-激酶(PI3K)途径的非选择性抑制剂)在SCC-25细胞系细胞存活和增殖中的作用
Asian Pac J Cancer Prev. 2019 Nov 1;20(11):3377-3383. doi: 10.31557/APJCP.2019.20.11.3377.
6
Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives.PTEN在乳腺癌中的预后及预测意义:虽未实现承诺,但前景引人入胜。
Cancers (Basel). 2019 Sep 19;11(9):1401. doi: 10.3390/cancers11091401.
7
Role of AKT and mTOR signaling pathways in the induction of epithelial-mesenchymal transition (EMT) process.AKT 和 mTOR 信号通路在诱导上皮-间充质转化(EMT)过程中的作用。
Biochimie. 2019 Oct;165:229-234. doi: 10.1016/j.biochi.2019.08.003. Epub 2019 Aug 8.
8
Phase II trial of an AKT inhibitor (perifosine) for recurrent glioblastoma.二期临床试验:一种 AKT 抑制剂(perifosine)治疗复发性脑胶质瘤。
J Neurooncol. 2019 Sep;144(2):403-407. doi: 10.1007/s11060-019-03243-7. Epub 2019 Jul 19.
9
Emerging role of PI3K/AKT in tumor-related epigenetic regulation.PI3K/AKT 在肿瘤相关表观遗传调控中的新兴作用。
Semin Cancer Biol. 2019 Dec;59:112-124. doi: 10.1016/j.semcancer.2019.04.001. Epub 2019 Apr 2.
10
Targeting PI3K in cancer: mechanisms and advances in clinical trials.针对癌症的 PI3K 靶向治疗:机制与临床试验进展。
Mol Cancer. 2019 Feb 19;18(1):26. doi: 10.1186/s12943-019-0954-x.